Steward Partners Investment Advisory LLC Has $160,000 Stock Position in Patterson Companies, Inc. (NASDAQ:PDCO)

Steward Partners Investment Advisory LLC grew its stake in shares of Patterson Companies, Inc. (NASDAQ:PDCO) by 591.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,186 shares of the company’s stock after purchasing an additional 4,436 shares during the quarter. Steward Partners Investment Advisory LLC’s holdings in Patterson Companies were worth $160,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the stock. US Bancorp DE increased its position in shares of Patterson Companies by 1.6% during the 4th quarter. US Bancorp DE now owns 32,767 shares of the company’s stock worth $1,011,000 after purchasing an additional 514 shares during the last quarter. Equity Investment Corp boosted its stake in shares of Patterson Companies by 16.6% during the 4th quarter. Equity Investment Corp now owns 2,028,964 shares of the company’s stock worth $62,614,000 after acquiring an additional 289,295 shares during the period. Bank of New York Mellon Corp boosted its stake in shares of Patterson Companies by 18.0% during the 4th quarter. Bank of New York Mellon Corp now owns 1,455,729 shares of the company’s stock worth $44,924,000 after acquiring an additional 222,005 shares during the period. Allianz Asset Management GmbH boosted its stake in shares of Patterson Companies by 3.7% during the 4th quarter. Allianz Asset Management GmbH now owns 1,186,906 shares of the company’s stock worth $36,628,000 after acquiring an additional 42,689 shares during the period. Finally, Wolverine Asset Management LLC bought a new position in shares of Patterson Companies during the 4th quarter worth approximately $785,000. Institutional investors and hedge funds own 85.43% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on PDCO shares. StockNews.com started coverage on Patterson Companies in a research note on Tuesday, March 11th. They set a “hold” rating for the company. Piper Sandler reduced their target price on Patterson Companies from $26.00 to $24.00 and set a “neutral” rating for the company in a research note on Friday, December 6th. Morgan Stanley lifted their target price on Patterson Companies from $27.00 to $31.35 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Robert W. Baird lifted their target price on Patterson Companies from $25.00 to $31.00 and gave the stock a “neutral” rating in a research note on Thursday, December 12th. Finally, Mizuho assumed coverage on Patterson Companies in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $23.00 price target for the company. Eleven equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $26.57.

Patterson Companies Stock Performance

NASDAQ:PDCO opened at $31.14 on Friday. The stock has a fifty day moving average price of $31.01 and a 200-day moving average price of $25.89. The company has a market cap of $2.76 billion, a price-to-earnings ratio of 18.21, a PEG ratio of 2.71 and a beta of 0.99. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.76 and a current ratio of 1.37. Patterson Companies, Inc. has a fifty-two week low of $19.45 and a fifty-two week high of $31.79.

Patterson Companies Profile

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.